12 Health Care Stocks Moving In Thursday's After-Market Session

周四盘后交易时段，12只医疗保健股走势

Benzinga Real-time News · 2022/04/15 05:50

Kaleido Biosciences (NASDAQ:KLDO) stock increased by 10.3% to $0.32 during Thursday's after-market session. Today's trading volume for this security ended up closing at 14.2 million shares, which is 369.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $13.6 million.
NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares moved upwards by 9.28% to $0.95. At the close, NeuroBo Pharmaceuticals's trading volume reached 232.9K shares. This is 119.9% of its average volume over the last 100 days. The company's market cap stands at $25.3 million.
ASLAN Pharma (NASDAQ:ASLN) shares rose 9.14% to $0.82. The market value of their outstanding shares is at $57.1 million.
Renalytix (NASDAQ:RNLX) stock moved upwards by 7.87% to $6.3. The company's market cap stands at $235.4 million.
Calyxt (NASDAQ:CLXT) stock rose 6.06% to $0.7. The company's market cap stands at $29.9 million.
aTyr Pharma (NASDAQ:LIFE) shares increased by 6.06% to $5.25. The market value of their outstanding shares is at $145.9 million.

Nektar Therapeutics (NASDAQ:NKTR) shares fell 22.1% to $4.8 during Thursday's after-market session. Nektar Therapeutics's trading volume hit 1.3 million shares by close, accounting for 41.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $894.1 million.
InVivo Therapeutics Hldg (NASDAQ:NVIV) stock declined by 8.95% to $0.27. This security traded at a volume of 80.1K shares come close, making up 15.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $9.4 million.
Evoke Pharma (NASDAQ:EVOK) stock fell 8.36% to $0.35. The market value of their outstanding shares is at $11.6 million.
Avenue Therapeutics (NASDAQ:ATXI) stock declined by 6.64% to $0.47. The company's market cap stands at $10.3 million.
Galectin Therapeutics (NASDAQ:GALT) shares declined by 6.33% to $1.63. This security traded at a volume of 519.1K shares come close, making up 525.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $96.7 million.
Immunogen (NASDAQ:IMGN) shares decreased by 5.43% to $5.06. The company's market cap stands at $1.1 billion. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Kaleido Biosciences (NASDAQ:KLDO) stock increased by 10.3% to $0.32 during Thursday's after-market session. Today's trading volume for this security ended up closing at 14.2 million shares, which is 369.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $13.6 million.
NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares moved upwards by 9.28% to $0.95. At the close, NeuroBo Pharmaceuticals's trading volume reached 232.9K shares. This is 119.9% of its average volume over the last 100 days. The company's market cap stands at $25.3 million.
ASLAN Pharma (NASDAQ:ASLN) shares rose 9.14% to $0.82. The market value of their outstanding shares is at $57.1 million.
Renalytix (NASDAQ:RNLX) stock moved upwards by 7.87% to $6.3. The company's market cap stands at $235.4 million.
Calyxt (NASDAQ:CLXT) stock rose 6.06% to $0.7. The company's market cap stands at $29.9 million.
aTyr Pharma (NASDAQ:LIFE) shares increased by 6.06% to $5.25. The market value of their outstanding shares is at $145.9 million.

卡莱多生物科学纳斯达克(KLDO：KLDO)股价周四盘后上涨10.3%，至0.32美元。该证券今日成交量为1,420万股，是过去100日平均成交量的369.4%。他们流通股的市值为1360万美元。
NeuroBo制药纳斯达克(Sequoia Capital：NRBO)股价上涨9.28%至0.95美元。收盘时，NeuroBo制药的成交量达到232.9万股。这是过去100日平均成交量的119.9。该公司的市值为2530万美元。
阿斯兰制药公司纳斯达克(Sequoia Capital：ASLN)股价上涨9.14%，至0.82美元。他们流通股的市值为5710万美元。
Renalytix纳斯达克(Tmall：RNLX)股价上涨7.87%，至6.3美元。该公司的市值为2.354亿美元。
Calyxt纳斯达克(Tmall：CLXT)股价上涨6.06%，至0.7美元。该公司的市值为2990万美元。
阿泰尔制药公司纳斯达克：LIFE)股价上涨6.06%，至5.25美元。他们流通股的市值为1.459亿美元。

Nektar Therapeutics (NASDAQ:NKTR) shares fell 22.1% to $4.8 during Thursday's after-market session. Nektar Therapeutics's trading volume hit 1.3 million shares by close, accounting for 41.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $894.1 million.
InVivo Therapeutics Hldg (NASDAQ:NVIV) stock declined by 8.95% to $0.27. This security traded at a volume of 80.1K shares come close, making up 15.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $9.4 million.
Evoke Pharma (NASDAQ:EVOK) stock fell 8.36% to $0.35. The market value of their outstanding shares is at $11.6 million.
Avenue Therapeutics (NASDAQ:ATXI) stock declined by 6.64% to $0.47. The company's market cap stands at $10.3 million.
Galectin Therapeutics (NASDAQ:GALT) shares declined by 6.33% to $1.63. This security traded at a volume of 519.1K shares come close, making up 525.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $96.7 million.
Immunogen (NASDAQ:IMGN) shares decreased by 5.43% to $5.06. The company's market cap stands at $1.1 billion. See Also:

Nektar治疗公司纳斯达克股价周四盘后下跌22.1%，至4.8美元。截至收盘，Nektar Treateutics的成交量达到130万股，占其过去100天平均成交量的41.9%。他们流通股的市值为8.941亿美元。
体内治疗Hldg纳斯达克股价下跌8.95%，至0.27美元。这只证券的成交量为80.1K股，接近于过去100天平均成交量的15.6%。他们流通股的市值为940万美元。
唤起药业纳斯达克：EVOK)股价下跌8.36%，至0.35美元。他们流通股的市值为1160万美元。
大道治疗公司纳斯达克(Tmall：ATXI)股价下跌6.64%，至0.47美元。该公司的市值为1,030万美元。
Galectin治疗药物纳斯达克股票代码：GALT)股价下跌6.33%，至1.63美元。这只证券的成交量为519.1K股，接近于过去100日平均成交量的525.0%。他们流通股的市值为9670万美元。
免疫基因纳斯达克(Tmall：IMGN)股价下跌5.43%，至5.06美元。该公司的市值为11亿美元。另见：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

风险及免责提示